CorrespondenceResearch LetterB7-1 Immunostaining in Proteinuric Kidney Disease
Research Letter
Section snippets
Acknowledgements
We thank Dr William Couser for reviewing the manuscript and our colleagues at Nephropath for input into the study.
Support: None.
Financial Disclosure: The authors declare that they have no relevant financial interests.
Contributions: Research idea and study design: CPL, NCM; data acquisition: CPL; data analysis/interpretation: CPL, NCM; supervision or mentorship: PDW. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the
References (7)
- et al.
Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?
Semin Nephrol
(2012) - et al.
Abatacept in B7-1-positive proteinuric kidney disease
N Engl J Med
(2013) - et al.
Induction of B7-1 in podocytes is associated with nephrotic syndrome
J Clin Invest
(2004)
There are more references available in the full text version of this article.
Cited by (0)
Originally published online September 30, 2014.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.